BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 37682035)

  • 1. Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.
    Peng K; Zou Z; Li J; Xie Y; Ming Z; Jiang T; Luo W; Hu X; Nie Y; Chen L; Luo T; Peng T; Ma D; Liu S; Luo ZY
    J Nat Prod; 2023 Sep; 86(9):2111-2121. PubMed ID: 37682035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
    Chang H; Jin L; Xie P; Zhang B; Yu M; Li H; Liu S; Yan J; Zhou B; Li X; Xu Y; Xiao Y; Ye Q; Guo L
    J Gastrointest Oncol; 2022 Oct; 13(5):2351-2365. PubMed ID: 36388659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis.
    Fan Q; Liu B
    Onco Targets Ther; 2017; 10():3591-3606. PubMed ID: 28790851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub genes and pathways in lung metastatic colorectal cancer.
    Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
    BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Wu S; Wu F; Jiang Z
    Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial-Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification.
    Guo S; Sun Y
    Cancer Manag Res; 2022; 14():1371-1384. PubMed ID: 35418782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis.
    Lv J; Li L
    Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.
    Xiaoyan F; Mingzhe LI; Long C; Chao L; Wenli LU; Zhiqiang P; Dongwei J; Peike P; Zhaoqin F; Xiaomei L
    J Tradit Chin Med; 2022 Dec; 42(6):922-931. PubMed ID: 36378050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
    Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
    Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer.
    Lee CC; Lee AW; Wei PL; Liu YS; Chang YJ; Huang CY
    Sci Rep; 2023 Mar; 13(1):4366. PubMed ID: 36927770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
    Chen L; Zhu Z; Gao W; Jiang Q; Yu J; Fu C
    Gene; 2017 Sep; 627():484-490. PubMed ID: 28687332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
    Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.